ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,946,000 | -61.5% | 788,585 | -22.2% | 0.12% | -51.2% |
| Q4 2021 | $28,458,000 | -21.8% | 1,014,185 | -5.2% | 0.25% | -20.5% |
| Q3 2021 | $36,379,000 | -17.5% | 1,070,285 | -0.9% | 0.32% | -12.2% |
| Q2 2021 | $44,108,000 | -1.8% | 1,079,485 | -3.3% | 0.36% | -6.2% |
| Q1 2021 | $44,926,000 | -44.5% | 1,115,885 | -18.4% | 0.38% | -41.4% |
| Q4 2020 | $80,894,000 | +14.8% | 1,368,063 | -5.6% | 0.66% | -0.5% |
| Q3 2020 | $70,458,000 | -7.5% | 1,448,863 | -8.0% | 0.66% | -9.2% |
| Q2 2020 | $76,193,000 | +63.7% | 1,574,890 | -6.0% | 0.73% | +31.0% |
| Q1 2020 | $46,548,000 | +4.4% | 1,675,590 | +12.4% | 0.56% | +39.4% |
| Q4 2019 | $44,607,000 | +31.0% | 1,490,881 | +35.2% | 0.40% | +32.2% |
| Q3 2019 | $34,062,000 | +56.5% | 1,102,321 | +144.6% | 0.30% | +80.2% |
| Q2 2019 | $21,769,000 | – | 450,700 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |